Calcineurin as a marker of myocardial hypertrophy in children with valvular congenital heart diseases

Authors

  • A. V. Kamenshchyk
  • T. B. Borisenko
  • T. F. Antishina
  • E. I. Rudova

DOI:

https://doi.org/10.14739/2310-1210.2015.3.44446

Keywords:

Calcineurin, Congenital Valvular Heart Diseases, Children

Abstract

Aim. To identify interrelations between the calcineurin levels in children with valvular congenital heart diseases without heart failure and the echocardiography parameters of myocardial hypertrophy.

Results: It was established the significantly decreased calcineurin level in congenial valvular heart diseases in children as well as an absence of correlations of the left ventricle myocardial mass and index with negative ones to the dimensions of right ventricle in comparison to healthy children of  corresponding age.

Conclusion: The obtained data testifies the importance of calcineurin system activity in the formation of pathologic myocardial hypertrophy in children with valvular congenital heart diseases and without manifestation of heart failure.

References

Tovillas_Moran, F., Zabaleta_del_Olmo, E., Dalfo_Baque A., Vilaplana-Cosculluela, M., Galcerán, J. M., & Coca, A. (2009) Rev. Cardiovascular morbidity and mortality and left ventricular geometric patterns in hypertensive patients treated in primary care. Esp. Cardiol., 62(3), 246–254.

Chahal, N. S., Lim, T. K., Jain, P., Chambers, J.C., Kooner, J. S., & Senior R. (2010) New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: a population study of hypertensive subjects. Eur Heart J., 31, 588–594. doi:10.1093/eurheartj/ehp490.

Kovaleva, О. N., & Sytina, I. V. (2013) Gipertrofiya miokarda levogo zheludochka i pokazateli bioe`nergeticheskikh processov u pacientov s gipertonicheskoj bolezn`yu sochetannoj s sakharnym diabetom 2-go tipa. [Left ventricle hypertrophy and parameters of bioenergetic processes in patients with hypertonic disease are combined to type 2 diabetes mellitus] Krovoobih ta hemostaz, 3–4, 59–64. [in Ukrainian].

Tzemos, N., Therrien, J., Yip, J., Thanassoulis, G., Tremblay, S., Jamorski, M. T., et al., (2008) Outcomes in Adults With Bicuspid Aortic Valves. JAMA, 300(11), 1317–1325. doi: 10.1001/jama.300.11.1317.

Wolska, B. M. (2009) Calcineurin and cardiac function: is more or less better for the heart? American Journal of Physiology - Heart and Circulatory Physiology, 297(5), H1576-H1577. doi:10.1152/ajpheart.00833.2009.

Musson, R. E., & Smit, N. P. (2011) Regulatory mechanisms of calcineurin phosphatase activity. Curr Med Chem., 18, 301–15.

Maillet, M., Davis, J., Auger-Messier, M., York, A., Osinska, H., Piquereau, J., et al (2010). Heart-specific deletion of CnB1 reveals multiple mechanisms whereby calcineurin regulates cardiac growth and function. J Biol Chem, 285, 6716–2. doi: 10.1074/jbc.M109.056143.

Rajapurohitam, V., Izaddoustdar, F., Martinez-Abundis, E., & Karmazyn, M. (2012) Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Cell Signal., 24(12), 2283-90. doi: 10.1016/j.cellsig.2012.07.025.

Kovacs, A., Weinheimer, C. J. et al. (2009) Impairedcontractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am J Physiol Heart Circ Physiol, 297, H1263-73. doi: 10.1152/ajpheart.00152.2009.

Alfieri, C. M., Cheek, J., Chakraborty, S., & Yutzey, K. E. (2010) Wnt signaling in heart valve development and osteogenic gene induction. Dev Biol., 338, 127–135. doi: 10.1016/j.ydbio.2009.11.030.

Bischoff, J., & Aikawa, E. (2011) Progenitor cells confer plasticity to cardiac valve endothelium. J Cardiovasc Transl Res., 4, 710–719. doi: 10.1007/s12265-011-9312-0.

Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol., 57(6), 450–458. doi: 10.1016/0002-9149(86)90771-X.

Gosse, P., Jullien, V., Jarnier, P., Lemetayer, P., & Clementy, J. (1999) Echocardiographic definition of left ventricular hypertrophy in the hypertensive: which method of indexation of left ventricular mass? J. Hum. Hypertens., 13, 505–509.

Downloads

How to Cite

1.
Kamenshchyk AV, Borisenko TB, Antishina TF, Rudova EI. Calcineurin as a marker of myocardial hypertrophy in children with valvular congenital heart diseases. Zaporozhye Medical Journal [Internet]. 2015Jun.15 [cited 2024Nov.24];17(3). Available from: http://zmj.zsmu.edu.ua/article/view/44446

Issue

No. 3 (2015): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)